Breaking News
EU regulators approve tolebrutinib, now Cenrifki, for nonrelapsing SPMS
Europe EU Watch

EU regulators approve tolebrutinib, now Cenrifki, for nonrelapsing SPMS

Source: news.google.com

Published: Jun 24, 2026 23:18

Read Original Source
EU regulators approve tolebrutinib, now Cenrifki, for nonrelapsing SPMS  Multiple Sclerosis News Today
Detailed source content is still being fetched from the original article. Use the source link above for the live story.

Related Stories

More from this topic and section

Add Shortcut

Add Newsfeed to your home screen

Open this site faster like an app from your phone home screen.

X in 3s